Schaefer F, Wingen A M, Hennicke M, Rigden S, Mehls O
Division of Pediatric Nephrology, University Children's Hospital, Heidelberg, Germany.
Pediatr Nephrol. 1996 Jun;10(3):288-93. doi: 10.1007/BF00866762.
Despite the high prevalence of and therapeutic attention to growth failure in children with chronic renal failure (CRF), systematic evaluations of spontaneous growth in CRF are lacking. Therefore, we collected retrospectively longitudinal growth and biochemical data in 321 prepubertal patients treated for CRF due to congenital renal disorders. Data were recorded at 3-month intervals during the first 2 years of life and 6-monthly thereafter, up to the age of 10 years. Around 100 measurements were available per age interval. Mixed-longitudinal percentile curves of height and height velocity were constructed. Moreover, a statistical comparison with the heights and height velocities of healthy children and an evaluation of the effect of biochemical parameters on growth was performed. The CRF children had normal heights at birth but dropped below the 3rd normal percentile during the first 15 months of life. Thereafter, growth patterns usually were percentile parallel, with a mean height standard deviation score (SDS) of -2.37 +/- 1.6. Height velocities were consistently lower in patients with glomerular filtration rates (GFRs) below one-third of the lower normal limit (25 ml/min per 1.73 m2 for patients > 1 year) than in patients with better renal function. This difference in growth rates resulted in a mean height SDS of -1.65 +/- 1.5 SDS and -2.79 +/- 1.4 SDS (age 1-10 years) in the subgroups with relatively better and worse GFR, respectively. Regression analysis confirmed that GFR was a weak but significant predictor of height velocity SDS in most age groups.
尽管慢性肾衰竭(CRF)患儿生长发育迟缓的患病率很高且受到了治疗关注,但仍缺乏对CRF患儿自然生长情况的系统评估。因此,我们回顾性收集了321例因先天性肾脏疾病接受CRF治疗的青春期前患者的纵向生长和生化数据。在生命的前2年,每3个月记录一次数据,此后每6个月记录一次,直至10岁。每个年龄区间约有100次测量数据。构建了身高和身高增长速度的混合纵向百分位数曲线。此外,还与健康儿童的身高和身高增长速度进行了统计学比较,并评估了生化参数对生长的影响。CRF患儿出生时身高正常,但在出生后的前15个月内降至正常百分位数第3以下。此后,生长模式通常与百分位数平行,平均身高标准差评分(SDS)为-2.37±1.6。肾小球滤过率(GFR)低于正常下限三分之一(1岁以上患者为每1.73平方米25毫升/分钟)的患者的身高增长速度始终低于肾功能较好的患者。生长速度的这种差异导致GFR相对较好和较差的亚组在1至10岁时的平均身高SDS分别为-1.65±1.5 SDS和-2.79±1.4 SDS。回归分析证实,在大多数年龄组中,GFR是身高增长速度SDS的一个弱但显著的预测指标。